Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations
Journal of Drugs in Dermatology · 01.04.2026 · 25 (4) · 363-367
DOI: 10.36849/jdd.9353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, online erschienen am 01.03.2026. Verfasst von Mallory A Von Lotten und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Hydroquinones, Hyperpigmentation, Skin Lightening Preparations, Dermatologic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Lotten, M. A. V., Bourne, A. K., Amechi, C., & Mayo, T. T. (2026). Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations. Journal of Drugs in Dermatology, 25(4), 363-367. https://doi.org/10.36849/jdd.9353
Vancouver
Lotten MAV, Bourne AK, Amechi C, Mayo TT. Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations. Journal of Drugs in Dermatology. 2026;25(4):363-367. doi:10.36849/jdd.9353
BibTeX
@article{Lotten2026,
author = {Lotten, Mallory A Von and Bourne, Aaliyah K and Amechi, Chiemelum and Mayo, Tiffany T},
title = {Hydroquinone and Emerging Depigmenting Agents: Clinical Guidelines, Regulatory History, and Global Safety Considerations},
journal = {Journal of Drugs in Dermatology},
year = {2026},
volume = {25},
number = {4},
pages = {363--367},
doi = {10.36849/jdd.9353}
}
EUVIMED